66 related articles for article (PubMed ID: 26026677)
21. Trastuzumab enhances the anti-tumor effects of the histone deacetylase inhibitor sodium butyrate on a HER2-overexpressing breast cancer cell line.
Chen W; Wei F; Xu J; Wang Y; Chen L; Wang J; Guan X
Int J Mol Med; 2011 Dec; 28(6):985-91. PubMed ID: 21887460
[TBL] [Abstract][Full Text] [Related]
22. Activation of ceramide synthase 6 by celecoxib leads to a selective induction of C16:0-ceramide.
Schiffmann S; Ziebell S; Sandner J; Birod K; Deckmann K; Hartmann D; Rode S; Schmidt H; Angioni C; Geisslinger G; Grösch S
Biochem Pharmacol; 2010 Dec; 80(11):1632-40. PubMed ID: 20735991
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models.
Gravina GL; Marampon F; Giusti I; Carosa E; Di Sante S; Ricevuto E; Dolo V; Tombolini V; Jannini EA; Festuccia C
Int J Oncol; 2012 Mar; 40(3):711-20. PubMed ID: 22134754
[TBL] [Abstract][Full Text] [Related]
24. YM753, a novel histone deacetylase inhibitor, exhibits antitumor activity with selective, sustained accumulation of acetylated histones in tumors in the WiDr xenograft model.
Shindoh N; Mori M; Terada Y; Oda K; Amino N; Kita A; Taniguchi M; Sohda KY; Nagai K; Sowa Y; Masuoka Y; Orita M; Sasamata M; Matsushime H; Furuichi K; Sakai T
Int J Oncol; 2008 Mar; 32(3):545-55. PubMed ID: 18292931
[TBL] [Abstract][Full Text] [Related]
25. A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes.
Gencer EB; Ural AU; Avcu F; Baran Y
Ann Hematol; 2011 Nov; 90(11):1265-75. PubMed ID: 21455605
[TBL] [Abstract][Full Text] [Related]
26. Reduced levels of the adenomatous polyposis coli (APC) protein are associated with ceramide-induced apoptosis of colon cancer cells.
Jaiswal AS; Narayan S
J Cancer Res Clin Oncol; 2004 Dec; 130(12):695-703. PubMed ID: 15340841
[TBL] [Abstract][Full Text] [Related]
27. New signalling pathway involved in the anti-proliferative action of vitamin D₃ and its analogues in human neuroblastoma cells. A role for ceramide kinase.
Bini F; Frati A; Garcia-Gil M; Battistini C; Granado M; Martinesi M; Mainardi M; Vannini E; Luzzati F; Caleo M; Peretto P; Gomez-Muñoz A; Meacci E
Neuropharmacology; 2012 Sep; 63(4):524-37. PubMed ID: 22579669
[TBL] [Abstract][Full Text] [Related]
28. Pan-histone deacetylase inhibitor panobinostat sensitizes gastric cancer cells to anthracyclines via induction of CITED2.
Regel I; Merkl L; Friedrich T; Burgermeister E; Zimmermann W; Einwächter H; Herrmann K; Langer R; Röcken C; Hofheinz R; Schmid R; Ebert MP
Gastroenterology; 2012 Jul; 143(1):99-109.e10. PubMed ID: 22465428
[TBL] [Abstract][Full Text] [Related]
29. A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.
Yu CC; Pan SL; Chao SW; Liu SP; Hsu JL; Yang YC; Li TK; Huang WJ; Guh JH
Biochem Pharmacol; 2014 Aug; 90(3):320-30. PubMed ID: 24915421
[TBL] [Abstract][Full Text] [Related]
30. Set-up of a new series of HDAC inhibitors: the 5,11-dihydrodibenzo[b,e]azepin-6-ones as privileged structures.
Bigioni M; Ettorre A; Felicetti P; Mauro S; Rossi C; Maggi CA; Marastoni E; Binaschi M; Parlani M; Fattori D
Bioorg Med Chem Lett; 2012 Sep; 22(17):5360-2. PubMed ID: 22877635
[TBL] [Abstract][Full Text] [Related]
31. Potential anti-cancer activity of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a histone deacetylase inhibitor, against breast cancer both in vitro and in vivo.
Park KC; Kim SW; Park JH; Song EH; Yang JW; Chung HJ; Jung HJ; Suh JS; Kwon HJ; Choi SH
Cancer Sci; 2011 Feb; 102(2):343-50. PubMed ID: 21159061
[TBL] [Abstract][Full Text] [Related]
32. Glucosylceramide synthase inhibitor PDMP sensitizes chronic myeloid leukemia T315I mutant to Bcr-Abl inhibitor and cooperatively induces glycogen synthase kinase-3-regulated apoptosis.
Huang WC; Tsai CC; Chen CL; Chen TY; Chen YP; Lin YS; Lu PJ; Lin CM; Wang SH; Tsao CW; Wang CY; Cheng YL; Hsieh CY; Tseng PC; Lin CF
FASEB J; 2011 Oct; 25(10):3661-73. PubMed ID: 21705667
[TBL] [Abstract][Full Text] [Related]
33. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species.
Rahmani M; Reese E; Dai Y; Bauer C; Payne SG; Dent P; Spiegel S; Grant S
Cancer Res; 2005 Mar; 65(6):2422-32. PubMed ID: 15781658
[TBL] [Abstract][Full Text] [Related]
34. Antitumor effects of a novel histone deacetylase inhibitor NK-HDAC-1 on breast cancer.
Li ZH; Zhang XB; Han XQ; Feng CR; Wang FS; Wang PG; Shen J; Shi YK
Oncol Rep; 2013 Jul; 30(1):499-505. PubMed ID: 23624828
[TBL] [Abstract][Full Text] [Related]
35. A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells.
Patra N; De U; Kim TH; Lee YJ; Ahn MY; Kim ND; Yoon JH; Choi WS; Moon HR; Lee BM; Kim HS
Biomed Pharmacother; 2013 Jun; 67(5):407-15. PubMed ID: 23583193
[TBL] [Abstract][Full Text] [Related]
36. Synthetic, non-natural analogs of ceramide elevate cellular ceramide, inducing apoptotic death to prostate cancer cells and eradicating tumors in mice.
Qin JD; Weiss L; Slavin S; Gatt S; Dagan A
Cancer Invest; 2010 Jun; 28(5):535-43. PubMed ID: 20014940
[TBL] [Abstract][Full Text] [Related]
37. The CLN3 gene is a novel molecular target for cancer drug discovery.
Rylova SN; Amalfitano A; Persaud-Sawin DA; Guo WX; Chang J; Jansen PJ; Proia AD; Boustany RM
Cancer Res; 2002 Feb; 62(3):801-8. PubMed ID: 11830536
[TBL] [Abstract][Full Text] [Related]
38. The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivo.
Lucas DM; Alinari L; West DA; Davis ME; Edwards RB; Johnson AJ; Blum KA; Hofmeister CC; Freitas MA; Parthun MR; Wang D; Lehman A; Zhang X; Jarjoura D; Kulp SK; Croce CM; Grever MR; Chen CS; Baiocchi RA; Byrd JC
PLoS One; 2010 Jun; 5(6):e10941. PubMed ID: 20532179
[TBL] [Abstract][Full Text] [Related]
39. Chemical synthesis and functional characterization of a new class of ceramide analogues as anti-cancer agents.
Liu Q; Li X; Bao YS; Lu J; Li H; Huang Z; Liu F
Bioorg Med Chem; 2019 Apr; 27(8):1489-1496. PubMed ID: 30837168
[TBL] [Abstract][Full Text] [Related]
40. The sphingosine kinase 2 inhibitor ABC294640 inhibits cervical carcinoma cell growth.
Xu L; Jin L; Yang B; Wang L; Xia Z; Zhang Q; Xu J
Oncotarget; 2018 Jan; 9(2):2384-2394. PubMed ID: 29416779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
